A Vetting Sequence, Not a Vendor List
Four checks in the order that eliminates the most sellers per minute spent, then an honest score for the one this page links to.
The useful answer to sermorelin where to buy is not a ranked list of storefronts, because the storefronts change faster than any list survives. It is a sequence of four checks, run in an order that eliminates the most sellers for the least reading, and it takes about twenty minutes.
Where the order actually gets placed
Ascension Peptides, Sermorelin
US-based and third-party tested. Enter the code on the payment step and the vial halves before you confirm.
The published certificate for lot 38-01260229 assays this vial at 11.31 mg against a 10 mg label, and reports purity and quantity only, with no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Batch certificate published for this lot
- Shipping free over $250
- Same-day dispatch before 2pm CST
Everything here is research material for laboratory use, not for human consumption. Affiliate links, so we may earn a commission at no cost to you. Prices last checked September 6, 2026.
Sermorelin where to buy: the checks in the order they pay off
Run them in this order deliberately. Identity comes first because a vial holding the wrong molecule makes every later question moot. Certificate scope comes second because it is the check most buyers skip and the one that most changes what you are actually accepting. Net content comes third because it silently rewrites the price. Terms come last because they matter only if the first three passed.
Most vetting guides invert this and start with shipping and refunds, which is why they take an hour and eliminate almost nobody.
Minutes one to five: identity
Sermorelin has a fixed and checkable identity. It is a synthetic twenty nine amino acid peptide equal to the active N-terminal fragment of human growth hormone-releasing hormone, GHRH(1-29) amide, with the sequence YADAIFTNSYRKVLGQLSARKLLQDIMSR and a C-terminal amide. PubChem CID 16132413 gives formula C149H246N44O42S and molecular weight 3357.9 g/mol.
Those numbers are the test. A certificate that reports a mass or a sequence you can match against them has told you the vial holds the compound named on the label. A certificate that reports only a purity percentage with no identity data has told you that whatever is in the vial is very pure, which is a different statement and a weaker one.
This check matters more for sermorelin than for most compounds because the shelf next to it is crowded with things that get sold as the same idea. Tesamorelin is a stabilised GHRH analog and is currently approved as Egrifta. Ipamorelin and MK-677 act at the ghrelin receptor rather than the GHRH receptor. They are four different purchases, and our guide to buying sermorelin as a peptide works through how to tell them apart on paper.
Minutes five to ten: what the certificate is scoped to test
This is where sellers separate, and it is not about pass or fail. Almost every published certificate passes. The question is what it was asked.
A purity and quantity certificate answers two things: what proportion of the material is the intended molecule, and how much material is in the vial. It does not answer whether the powder carries bacterial endotoxin, and it does not answer whether the fill was sterile. Those are separate assays with separate names.
FDA's own stated concern for the peptides it placed in Category 2 is the "risk for immunogenicity ... due to the potential for aggregation and peptide-related impurities". That is an impurities question, and an HPLC purity figure is a partial answer to it at best. So the scope of the certificate is not a technicality. It is the difference between a document that addresses the regulator's stated worry and one that addresses the seller's marketing.
Read scope as a property of the lot, not of the brand. The same supplier can publish a purity-only certificate on one batch and a fuller panel on another, which is exactly why the check is worth running each time rather than once.
Minutes ten to fifteen: net content, and the price it rewrites
Net content is the number almost nobody publishes and almost everybody assumes. A 10 mg label is a claim about intent. A measured quantity is a claim about the vial.
When a supplier does publish it, the figure can go either way, and publishing it at all means accepting that risk in public. On lot 38-01260229 it went up: MZ Biolabs measured 11.31 mg against a 10 mg label, an overfill of 13.1 percent on that batch.
That single figure moves the per-milligram cost from $3.60 to $3.18 at the $36.00 checkout price. It is worth stressing that this applies to that lot and nothing else. The full arithmetic, including what quantity tiers do and do not stack with, is on our sermorelin price page.
Minutes fifteen to twenty: terms, paperwork and what the seller claims
By now most sellers have gone. The survivors get the boring checks: is there a named laboratory with a real address on the certificate, is there a lot number that matches your stock, is there a refund position stated before checkout rather than discovered after it, and does the listing stay inside what a research supplier is allowed to say.
That last one cuts both ways. A listing that promises outcomes has told you it does not understand its own position. A listing that carries a plain research use designation is behaving normally, and the designation is not an admission that the compound is disreputable.
Supplier or repackager, and why the gap is narrower than it sounds
The framework is usually sold as a way to tell a real supplier from a repackager, which implies the second is a fraud. Mostly it is not. A large part of this market buys bulk powder, fills vials, labels them and ships, and that is an ordinary business rather than a scam.
What changes is who can answer a question. A firm that had the material made to its own order and paid for the testing can tell you which synthesis run your vial came from. A firm that bought a drum and filled from it can tell you what the drum's certificate said, which is a real answer but a shorter one. Neither is disqualifying. Both are worth knowing before you attribute a result to a brand rather than to a batch.
The practical test is not what a seller calls itself. It is whether the document you are shown carries a lot number that matches the vial you are sent, and whether the seller reacts helpfully when it does not. Anyone can publish a good certificate. Fewer can publish the certificate that belongs to your parcel.
There is a second, quieter version of the same problem. A certificate can be genuine, current and correctly matched, and still be from a laboratory nobody can find. A named analyst at a named address in a named city is not proof of competence, but it is a claim someone can be held to, and it is absent from a surprising share of this market. On the lot considered here, the report is signed by Ken Pendarvis at MZ Biolabs in Tucson, with the analysis dated 7 February 2026 and the signature dated the thirteenth. Those are checkable specifics rather than a logo.
Scoring the vendor this page links to
We link Ascension, so the framework has to be applied to it in public rather than quietly skipped.
| Criterion | What a pass looks like | Lot 38-01260229 | Score |
|---|---|---|---|
| Identity confirmed | Sequence or mass matching GHRH(1-29) | Sequence converts to the canonical 29-residue peptide | Pass |
| Purity by HPLC | A chromatographic method, tied to your lot | 99.79 percent, HPLC-UV-MS, four peaks detected | Pass |
| Named laboratory | Real name and address, named analyst | MZ Biolabs, Tucson AZ, analyst Ken Pendarvis | Pass |
| Batch-specific document | Lot number printed on the certificate | Lot 38-01260229, analysed 7 February 2026 | Pass |
| Net content measured | A weighed quantity, not a label claim | 11.31 mg against a 10 mg label | Pass |
| Endotoxin screen | An LAL result on your batch | Absent from this certificate | Fail |
| Sterility screen | A sterility result on your batch | Absent from this certificate | Fail |
| Terms stated up front | Pricing and shipping thresholds before checkout | List $99.99, site $72.00, $36.00 with the code, free shipping from $250 | Pass |
Six passes and two failures, and the two failures are in the category that matters most for anything sold as a powder to be put into solution. That is the honest score. It is better than most of this market publishes and it is not a clean sheet, and a page that told you only the first half of that sentence would not be worth reading.
The channel this framework does not cover
Everything above assumes a research supplier. Sermorelin is the rare compound where that is not the only option, because its regulatory history is genuinely different from the rest of the peptide market.
Geref was an approved US product: NDA 019863 for pituitary diagnostics, with submissions from May 1991, and NDA 020443 approved on 26 September 1997, both from EMD Serono. Both are discontinued now, and FDA's record carries the determination that the product was not discontinued or withdrawn for safety or effectiveness reasons. Sermorelin does not appear anywhere on FDA's Category 2 bulk substances list, in any section, while ibutamoren mesylate sits on it under both 503A and 503B.
That absence is what leaves a 503A compounding route open, and it means the vetting framework above is not the only path to a vial. The trade is time and a prescriber's involvement against speed and price, and the channel comparison sets out what each side of that trade actually asks of you.
One thing the framework cannot check for you: the literature. PubMed returns 332 papers mentioning sermorelin, three with it in the title, and zero for sermorelin and anti-aging. A supplier can pass every check on this page and still be selling into a market whose central promise the evidence does not reach.